Treatment of psoriasis. Part 2. Systemic therapies
- PMID: 11606913
- DOI: 10.1067/mjd.2001.117047
Treatment of psoriasis. Part 2. Systemic therapies
Abstract
The array of systemic medications used in the treatment of psoriasis is rapidly expanding. In the United States, methotrexate, retinoids, and cyclosporine are the only systemic drugs approved by the Food and Drug Administration for the treatment of psoriasis. Monitoring and dosage recommendations for these medications are reviewed. Other drugs that are currently available include tacrolimus, mycophenolate mofetil, hydroxyurea, 6-thioguanine, and sulfasalazine. Experience with these drugs is summarized, and dosage and monitoring recommendations in published literature are presented. Combinations of different treatments are addressed and investigational therapies that are in development are reviewed.
Comment in
-
Liver biopsy in patients without psoriasis receiving methotrexate: what guidelines are medical dermatologists following?J Am Acad Dermatol. 2004 Jun;50(6):e11. doi: 10.1016/S0190. J Am Acad Dermatol. 2004. PMID: 15153917 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical